Clinical data | |
---|---|
Other names | RBX-7644 |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H24FN5O6 |
Molar mass | 461.450 g·mol−1 |
3D model (JSmol) | |
| |
|
Ranbezolid (RBx7644) is an oxazolidinone antibacterial. It competitively inhibits monoamine oxidase-A (MAO-A).[1]
| |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
30S |
| ||||||||||||||
50S |
| ||||||||||||||
EF-G |
| ||||||||||||||
|
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |